Medicare Clinical Trial Coverage For IND-Exempt Trials Sought By PhRMA
Executive Summary
PhRMA is urging the Health Care Financing Administration to include permanent automatic qualification for IND-exempt trials in its Medicare clinical trial coverage policy.